Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Financial Conflicts of Interest Checklist 2010 for clinical research studies.

Rochon PA, Hoey J, Chan AW, Ferris LE, Lexchin J, Kalkar SR, Sekeres M, Wu W, Van Laethem M, Gruneir A, Maskalyk J, Streiner DL, Gold J, Taback N, Moher D.

Open Med. 2010;4(1):e69-91. Epub 2010 Mar 24.

2.

Genome-wide association study (GWAS)-identified disease risk alleles do not compromise human longevity.

Beekman M, Nederstigt C, Suchiman HE, Kremer D, van der Breggen R, Lakenberg N, Alemayehu WG, de Craen AJ, Westendorp RG, Boomsma DI, de Geus EJ, Houwing-Duistermaat JJ, Heijmans BT, Slagboom PE.

Proc Natl Acad Sci U S A. 2010 Oct 19;107(42):18046-9. doi: 10.1073/pnas.1003540107. Epub 2010 Oct 4.

3.

The emergence of translational epidemiology: from scientific discovery to population health impact.

Khoury MJ, Gwinn M, Ioannidis JP.

Am J Epidemiol. 2010 Sep 1;172(5):517-24. doi: 10.1093/aje/kwq211. Epub 2010 Aug 5.

4.

Improvement of risk prediction by genomic profiling: reclassification measures versus the area under the receiver operating characteristic curve.

Mihaescu R, van Zitteren M, van Hoek M, Sijbrands EJ, Uitterlinden AG, Witteman JC, Hofman A, Hunink MG, van Duijn CM, Janssens AC.

Am J Epidemiol. 2010 Aug 1;172(3):353-61. doi: 10.1093/aje/kwq122. Epub 2010 Jun 18.

PMID:
20562194
5.

Researching genetic versus nongenetic determinants of disease: a comparison and proposed unification.

Ioannidis JP, Loy EY, Poulton R, Chia KS.

Sci Transl Med. 2009 Nov 18;1(7):7ps8. doi: 10.1126/scitranslmed.3000247.

PMID:
20368180
6.

The quality of reports of randomised trials in 2000 and 2006: comparative study of articles indexed in PubMed.

Hopewell S, Dutton S, Yu LM, Chan AW, Altman DG.

BMJ. 2010 Mar 23;340:c723. doi: 10.1136/bmj.c723.

7.

Application of support vector machine modeling for prediction of common diseases: the case of diabetes and pre-diabetes.

Yu W, Liu T, Valdez R, Gwinn M, Khoury MJ.

BMC Med Inform Decis Mak. 2010 Mar 22;10:16. doi: 10.1186/1472-6947-10-16.

8.

Guidance for developers of health research reporting guidelines.

Moher D, Schulz KF, Simera I, Altman DG.

PLoS Med. 2010 Feb 16;7(2):e1000217. doi: 10.1371/journal.pmed.1000217.

9.

Assessment of improved prediction beyond traditional risk factors: when does a difference make a difference?

Janssens AC, Khoury MJ.

Circ Cardiovasc Genet. 2010 Feb;3(1):3-5. doi: 10.1161/CIRCGENETICS.110.938092. No abstract available.

10.

Utility of genetic and non-genetic risk factors in prediction of type 2 diabetes: Whitehall II prospective cohort study.

Talmud PJ, Hingorani AD, Cooper JA, Marmot MG, Brunner EJ, Kumari M, Kivimäki M, Humphries SE.

BMJ. 2010 Jan 14;340:b4838. doi: 10.1136/bmj.b4838.

11.

Genetic risk information for common diseases may indeed be already useful for prevention and early detection.

Gulcher J, Stefansson K.

Eur J Clin Invest. 2010 Jan;40(1):56-63. doi: 10.1111/j.1365-2362.2009.02233.x. No abstract available.

PMID:
20055896
12.

A catalogue of reporting guidelines for health research.

Simera I, Moher D, Hoey J, Schulz KF, Altman DG.

Eur J Clin Invest. 2010 Jan;40(1):35-53. doi: 10.1111/j.1365-2362.2009.02234.x. Review.

PMID:
20055895
13.

Assessing the performance of prediction models: a framework for traditional and novel measures.

Steyerberg EW, Vickers AJ, Cook NR, Gerds T, Gonen M, Obuchowski N, Pencina MJ, Kattan MW.

Epidemiology. 2010 Jan;21(1):128-38. doi: 10.1097/EDE.0b013e3181c30fb2.

14.

Assessment of claims of improved prediction beyond the Framingham risk score.

Tzoulaki I, Liberopoulos G, Ioannidis JP.

JAMA. 2009 Dec 2;302(21):2345-52. doi: 10.1001/jama.2009.1757. Review.

PMID:
19952321
15.

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.

Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D.

PLoS Med. 2009 Jul 21;6(7):e1000100. doi: 10.1371/journal.pmed.1000100. Epub 2009 Jul 21.

16.

Common polygenic variation contributes to risk of schizophrenia and bipolar disorder.

International Schizophrenia Consortium, Purcell SM, Wray NR, Stone JL, Visscher PM, O'Donovan MC, Sullivan PF, Sklar P.

Nature. 2009 Aug 6;460(7256):748-52. doi: 10.1038/nature08185. Epub 2009 Jul 1.

17.

Prognosis and prognostic research: application and impact of prognostic models in clinical practice.

Moons KG, Altman DG, Vergouwe Y, Royston P.

BMJ. 2009 Jun 4;338:b606. doi: 10.1136/bmj.b606. No abstract available.

PMID:
19502216
19.

Prognosis and prognostic research: validating a prognostic model.

Altman DG, Vergouwe Y, Royston P, Moons KG.

BMJ. 2009 May 28;338:b605. doi: 10.1136/bmj.b605. No abstract available.

PMID:
19477892
20.

Combined analysis of 19 common validated type 2 diabetes susceptibility gene variants shows moderate discriminative value and no evidence of gene-gene interaction.

Sparsø T, Grarup N, Andreasen C, Albrechtsen A, Holmkvist J, Andersen G, Jørgensen T, Borch-Johnsen K, Sandbaek A, Lauritzen T, Madsbad S, Hansen T, Pedersen O.

Diabetologia. 2009 Jul;52(7):1308-14. doi: 10.1007/s00125-009-1362-3. Epub 2009 Apr 29.

PMID:
19404609

Supplemental Content

Support Center